Therapeutic efficacy of cyclophosphamide as a function of its metabolism.
D000081:Acetamides / Q000494:pharmacology; D000818:Animals; D002279:Carcinoma 256, Walker / Q000378:metabolism; D003035:Cobalt / Q000494:pharmacology; D003520:Cyclophosphamide / Q000378:metabolism* / Q000627:therapeutic use / Q000633:toxicity; D003580:Cytochromes / Q000378:metabolism; D005260:Female; D066298:In Vitro Techniques; D007700:Kinetics; D007958:Leukocyte Count; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology; D008862:Microsomes, Liver / Q000201:enzymology / Q000378:metabolism*; D009020:Morphine / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D051381:Rats; D012965:Sodium Chloride / Q000494:pharmacology; D013440:Sulfides / Q000494:pharmacology
D000081:Acetamides; D003580:Cytochromes; D013440:Sulfides; D003035:Cobalt; D012965:Sodium Chloride; D008748:Methylcholanthrene; D009020:Morphine; D003520:Cyclophosphamide; D010634:Phenobarbital